Molecular Partners
is a Switzerland-based biotechnology company that develops and commercializes custom-built protein therapeutics for the treatment of cancer... Read moreMolecular Partners
is a Switzerland-based biotechnology company that develops and commercializes custom-built protein therapeutics for the treatment of cancer... Read more
News
May 12, 2026
FinanzNachrichten
Molecular Partners: Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317
May 04, 2026
Benzinga
Molecular Partners: Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences
May 01, 2026
FinanzNachrichten
Molecular Partners: Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling
Apr 19, 2026
Benzinga
Molecular Partners: Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712
Mar 19, 2026
Benzinga
Molecular Partners: Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins' Amenability to Multiple Isotopes
Mar 17, 2026
FinanzNachrichten
Molecular Partners: Molecular Partners to Hold Three Poster Presentations at AACR 2026
Mar 17, 2026
Seeking Alpha
Molecular Partners: Molecular Partners AG 2025 Q4 - Results - Earnings Call Presentation
Mar 12, 2026
FinanzNachrichten
Molecular Partners: Molecular Partners Reports Highlights and Financial Results for Full Year 2025
Mar 12, 2026
Benzinga
Molecular Partners: Molecular Partners Q4 EPS $(0.41) Misses $(0....
Mar 06, 2026
European Biotechnology
Molecular Partners: Radioligands give Molecular Partners fresh momentum in catching the train that is in full speed already
Molecular Partners Competitors
1
2
3
4
5
6
7
8
9
10